Information was omitted from Table 1 on page 596 of the article, Makin V, Lansang MC. Diabetes management: beyond hemoglobin A1c (Cleve Clin J Med 2019; 86(9):595–600, doi:10.3949/ccjm.86a.18031.
View this table:
TABLE 1
Advantages of selected type 2 diabetes drugs
The sodium-glucose cotransporter 2 (SGLT2) inhibitors pose a low risk of hypoglyemia, and that should have been noted in the table. The corrected table appears below and online.
- © 2019 The Cleveland Clinic Foundation. All Rights Reserved.
Jump to section
Related Articles
Cited By...
- No citing articles found.